Sanofi
SNY
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, otā¦ read more
Healthcare
Drug ManufacturersāGeneral
24 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$42.95
Price-0.30%
-$0.13
1Y
Price
Market Cap
$103.132b
Large
Price/Earnings 3y Avg5y Avg
9.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in EUR.+13.6%
EBITDA Margin+2.8%
Net Profit Margin+13.7%
Free Cash Flow Margin+13.6%
EBITDA Margin+2.8%
Net Profit Margin+13.7%
Free Cash Flow MarginRevenue
$48.919b
+4.7%
1y CAGR+5.5%
3y CAGR+4.8%
5y CAGREarnings
$3.958b
-49.3%
1y CAGR-1.9%
3y CAGR-10.3%
5y CAGREPS
$0.49
-84.7%
1y CAGR-12.2%
3y CAGR-17.3%
5y CAGRBook Value
$69.567b
$129.060b
Assets$59.493b
Liabilities$23.576b
DebtDebt to Assets
18.3%
1.9x
Debt to EBITDAFree Cash Flow
$7.865b
-22.5%
1y CAGR+6.0%
3y CAGR+5.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company